Gabather AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Gabather AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8127
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gabather AB (Gabather) is a developer of new drug candidates for the treatment of central nervous system diseases. The company spans its expertise in the development of anti-psychotics, anti-depressants and anxiolytics, analgesics, and cognition-enhancing treatments. It offers drug candidates in form of small molecules that integrate with the Gaba receptor complex in the brain. The company targets diseases include learning, cognition, sleep regulation, pain, anxiety, epilepsy, muscular tension and addiction, among others. It serves in the US, Canada, China and India. Gabather is headquartered in Malmo, Sweden.

Gabather AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gabather AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gabather AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 10
Gabather Enters into Research Agreement with UNSW 11
Equity Offering 12
Gabather Raises USD3.2 Million in Rights Offering of Units 12
Gabather to Raise up to USD4 Million in Rights Offering of Shares 13
Gabather Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14
Gabather Raises USD1 Million in Offering of Units 15
Gabather AB – Key Competitors 16
Gabather AB – Key Employees 17
Gabather AB – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Gabather AB, Pharmaceuticals & Healthcare, Key Facts 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Deals By Therapy Area, 2012 to YTD 2018 8
Gabather AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 10
Gabather Enters into Research Agreement with UNSW 11
Gabather Raises USD3.2 Million in Rights Offering of Units 12
Gabather to Raise up to USD4 Million in Rights Offering of Shares 13
Gabather Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants 14
Gabather Raises USD1 Million in Offering of Units 15
Gabather AB, Key Competitors 16
Gabather AB, Key Employees 17

List of Figures
Gabather AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Gabather AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gabather AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Gabather AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gabather AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Gabather AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qatar Electricity & Water Co QPSC (QEWS):電力:M&Aディール及び事業提携情報
    Summary Qatar Electricity & Water Co QPSC (QEWC), formerly Qatar Electricity & Water Company QSC, is an electricity and water utility. It generates electricity and desalinates water. The company owns and operates various power generation and water desalination stations and substations primarily in Q …
  • Norwegian Energy Company ASA (NOR):企業の財務・戦略的SWOT分析
    Summary Norwegian Energy Company ASA (Noreco) is an oil and gas company that offers exploration and development services. The company explores, produces and develops oil, gas, and natural gas liquids deposit properties. It operates through ongoing and planned exploration wells such as PL616 Haribo a …
  • Bird Construction Inc (BDT):企業の財務・戦略的SWOT分析
    Bird Construction Inc (BDT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • IP Group Plc (IPO):企業の財務・戦略的SWOT分析
    Summary IP Group Plc (IP Group) is a provider of venture capital, business building and support, networks and recruitment services. The company invests in companies, which comprise early stage to mature businesses from various sectors such as energy and renewables, medical equipment and supplies, ph …
  • Prudential Financial, Inc.:企業のM&A・事業提携・投資動向
    Prudential Financial, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Prudential Financial, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Tubacero S. de RL de CV:企業の戦略・SWOT・財務情報
    Tubacero S. de RL de CV - Strategy, SWOT and Corporate Finance Report Summary Tubacero S. de RL de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BDO Unibank Inc:企業の戦略・SWOT・財務情報
    BDO Unibank Inc - Strategy, SWOT and Corporate Finance Report Summary BDO Unibank Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sc Arcada Con Srl:企業の戦略的SWOT分析
    Sc Arcada Con Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Defense Commissary Agency:企業の戦略的SWOT分析
    Defense Commissary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Bone Therapeutics SA (BOTHE):医療機器:M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • United Supermarkets LLC:企業の戦略・SWOT・財務情報
    United Supermarkets LLC - Strategy, SWOT and Corporate Finance Report Summary United Supermarkets LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Oil States International Inc (OIS):企業の財務・戦略的SWOT分析
    Oil States International Inc (OIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Industrial Development Company s.a.l.:企業の戦略・SWOT・財務分析
    Industrial Development Company s.a.l. - Strategy, SWOT and Corporate Finance Report Summary Industrial Development Company s.a.l. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Essentra Plc (ESNT):企業の財務・戦略的SWOT分析
    Essentra Plc (ESNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Relief Therapeutics Holding AG (RLF):企業の財務・戦略的SWOT分析
    Summary Relief Therapeutics Holding AG (Relief Therapeutics) is a drug development company that offers clinical development of peptides and proteins of natural or engineered origin. Its pipeline drug candidates include aviptadil for the treatment of sarcoidosis and low dose interleukin-6 to treat pe …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • CellProthera-製薬・医療分野:企業M&A・提携分析
    Summary CellProthera (CellProthera) focuses on the development of therapeutic solutions for the regeneration of organs which are damaged by disease or trauma from autologous blood peripheral stem cells. The company’s lead candidate ProtheraCytes, is an advanced therapy medicinal product within tissu …
  • Energias de Portugal SA:発電所・企業SWOT分析
    Energias de Portugal SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆